Type of security: Stock
Sector: Health Care
Industry: Hospital/Nursing Management
The data is delayed by 15 minutes.
Description: DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease. It operates kidney dialysis centers and provides related lab services primarily in outpatient dialysis centers and in contracted hospitals. The company offers outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers DaVita Rx, a pharmacy that provides oral medications to patients with ESRD; disease management services; vascular access services; ESRD clinical research programs; physician services; and direct primary care services. As of March 31, 2014, it operated 2,173 outpatient dialysis centers, including 2,098 centers located in the United States; and 75 centers located in 10 countries outside the United
See how to gain 20% in 14 sec with TrendsInvesting
|Shares Outstanding||EPS||EPS Growth - 4 Quarters||-232.26%||EPS Growth - Q/Q||-192.85%|
|EPS Growth - Y/Y||16.12%||Sales Growth - 4 Quarters||3.64%||Sales Growth - Q/Q||-1.2%||P/E|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||2.34%||ROE||7.37%||ROI||3.12%|
|Current Ratio||1.61||Quick Ratio||1.55||Long Term Debt/Equity||5.17||Debt Ratio||0.46|
|Gross Margin||28.67%||Operating Margin||10.04%||Net Profit Margin||3.29%||Dividend Payout Ratio||-36.74%|
|Cash From Financing Activities||-110.87 M||Cash From Investing Activities||-252.29 M||Cash From Operating Activities||410.09 M||Gross Profit||925.35 M|
|Net Profit||-110.62 M||Operating Profit||-64.16 M||Total Assets||18.37 B||Total Current Assets||4.3 B|
|Total Current Liabilities||2.68 B||Total Debt||8.5 B||Total Liabilities||13.4 B||Total Revenue||3.29 B|
|High 52 week||76.08||Low 52 week||43.42||Last close||59.69||Last change||-0.17%|
|RSI||56.53||Average true range||1.28||Beta||0.63||Volume||417.62 K|
|Simple moving average 20 days||1.52%||Simple moving average 50 days||9.35%||Simple moving average 200 days||6.41%|
|Performance Week||-0.68%||Performance Month||5.81%||Performance Quart||14.55%||Performance Half||6.34%|
|Performance Year||-16.52%||Performance Year-to-date||15.99%||Volatility daily||1.43%||Volatility weekly||3.2%|
|Volatility monthly||6.55%||Volatility yearly||22.71%||Relative Volume||157.6%||Average Volume||2.26 M|
|New High||New Low|
2019-10-17 07:27:09 | Do DaVita Inc.’s NYSE:DVA Returns On Capital Employed Make The Cut?
2019-10-16 06:17:00 | DaVita's Corporate Responsibility Efforts Earn Accolades from Dow Jones
2019-10-15 09:36:05 | Moody's: Passage of AB-290 in California is credit negative for DaVita
2019-10-12 14:19:17 | Hedge Fund Sentiment Unchanged On DaVita Inc DVA
2019-10-10 12:50:00 | 13th Annual Tour DaVita Cycling Event Raises $1.2M for Bridge of Life
2019-10-09 09:25:01 | Here's Why You Should Retain DaVita DVA Stock for Now
2019-10-01 09:15:01 | September Not As Tough As Feared
2019-09-23 17:19:39 | Jim Chanos: This Berkshire Hathaway-Backed Health Care Company Is an Insurance Fraud
2019-09-21 14:15:19 | Tesla Bear Jim Chanos Shorting Grubhub, DaVita
2019-09-21 09:07:20 | Is DaVita Inc.'s NYSE:DVA 13% ROE Better Than Average?
2019-09-19 16:58:26 | US Markets Green on Thursday
2019-09-19 12:33:00 | Jim Chanos unveils short position in kidney-dialysis firm DaVita
2019-09-19 11:15:17 | 11 Most Aggressively Shorted Stocks
2019-09-18 09:20:01 | 5 Low Price-to-Book Stocks to Increase Your Portfolio's Value
2019-09-17 11:21:50 | Jim Cramer Gives His Opinion On Ulta Beauty, Davita And More
2019-09-16 09:30:01 | DVA vs. AMED: Which Stock Should Value Investors Buy Now?
2019-09-16 08:41:12 | 5 Buffett-Style Value Picks Boasting Impressive PEG Ratio
2019-09-11 15:34:41 | Wall Street Edges Higher Wednesday
2019-09-10 07:20:11 | 5 Stocks With Amazingly Low EV/EBITDA Ratios to Own Now
2019-09-09 11:27:03 | The Zacks Analyst Blog Highlights: Exantas, Chemed, Viad, Arbor Realty and DaVita
2019-09-06 18:54:01 | 3 Predictable Stocks Warren Buffett and Ray Dalio Agree On
2019-09-06 07:12:11 | Strong ISM Services Index Eases Recession Fears: 5 Top Picks
2019-09-05 08:05:12 | 5 Price-to-Book Value Picks for September
2019-09-04 12:52:21 | Wall Street Red in the 1st Trading Day of September
2019-09-04 09:15:01 | Stocks Slide to Start September
2019-08-31 09:31:01 | Why Is DaVita HealthCare DVA Down 5% Since Last Earnings Report?
2019-08-29 16:10:08 | Draghi Says Goodbye. Should You Care?
2019-08-29 15:54:07 | When to Buy Global Markets?
2019-08-29 09:40:01 | DVA vs. CHE: Which Stock Is the Better Value Option?
2019-08-28 08:36:12 | 5 Stocks From the Best Performing Sectors in Q2
2019-08-27 06:35:00 | DaVita Inc. Schedules Capital Markets Day for September 10, 2019
2019-08-26 12:12:07 | Does DaVita NYSE:DVA Have A Healthy Balance Sheet?
2019-08-22 16:24:15 | Andreas Halvorsen Keeps Buying Centene, DaVita
2019-08-22 06:30:00 | Davita Announces Final Results Of Self-Tender Offer
2019-08-21 09:12:46 | DaVita buys back $1.2 billion worth of stock from shareholders
2019-08-20 07:45:11 | Here's Why You Should Invest in DaVita DVA Stock For Now
2019-08-19 17:21:21 | Wall Street Rallies Monday
2019-08-19 09:35:01 | Is DaVita DVA a Profitable Stock for Value Investors Now?
2019-08-19 06:55:10 | 5 Price-to-Book Value Picks to Improve Portfolio Returns
2019-08-19 06:30:00 | DaVita Announces Preliminary Results Of Self-Tender Offer
2019-08-16 16:09:06 | Main Wall Street Indexes Extend Gains Friday
2019-08-16 08:53:12 | Outlook for Outpatient and Home Healthcare Industry Looks Bright
2019-08-16 07:16:58 | SSM Health partners with Denver firm to offer new primary care option
2019-08-13 09:30:01 | DVA or CHE: Which Is the Better Value Stock Right Now?
2019-08-13 09:26:01 | 5 Safe Picks Amid Yield Inversion and Geopolitical Concerns